Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOGETHER-Toronto: Peginterferon lambda for COVID-19
NCT04967430Phase 3Unknown
- Sponsor
- University Health Network
- Start
- Aug 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon lambda-1a in coronavirus disease 2019 (COVID-19), sponsored by University Health Network. Status: unknown.
02
Drugs
peginterferon lambda-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04967430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967430.